Aceprometazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aceprometazine.
Acetyl salicylate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acetylsalicylic acid.
Acrivastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acrivastine.
Advertisement
Adrafinil
Hyaluronidase may increase the vasoconstricting activities of Adrafinil.
Alcaftadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Alcaftadine.
Alclometasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Alclometasone.
Advertisement
Aldosterone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aldosterone.
Aloxiprin
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aloxiprin.
Alprazolam
The therapeutic efficacy of Alprazolam can be decreased when used in combination with Hyaluronidase.
Advertisement
Amcinonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Amcinonide.
Aminosalicylic Acid
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aminosalicylic Acid.
Amitriptyline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Amitriptyline.
Amoxapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Amoxapine.
Androstenedione
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Androstenedione.
Antazoline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Antazoline.
Apomorphine
Hyaluronidase may increase the vasoconstricting activities of Apomorphine.
Apraclonidine
Hyaluronidase may increase the vasoconstricting activities of Apraclonidine.
Aripiprazole
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Articaine.
Asenapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Asenapine.
Aspirin
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Acetylsalicylic acid.
Astemizole
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Astemizole.
Azatadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Azatadine.
Azelastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Azelastine.
Balsalazide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Balsalazide.
Bazedoxifene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Bazedoxifene.
Beclomethasone Dipropionate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Beclomethasone dipropionate.
Benoxinate
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Oxybuprocaine.
Benzocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Benzocaine.
Benzphetamine
Hyaluronidase may increase the vasoconstricting activities of Benzphetamine.
Benzquinamide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzquinamide.
Benztropine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzatropine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Benzyl alcohol.
Bepotastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Bepotastine.
BETAHISTINE
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Betahistine.
Betamethasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Betamethasone.
Brimonidine
Hyaluronidase may increase the vasoconstricting activities of Brimonidine.
Bromazepam
The therapeutic efficacy of Bromazepam can be decreased when used in combination with Hyaluronidase.
Bromocriptine
Hyaluronidase may increase the vasoconstricting activities of Bromocriptine.
Bromodiphenhydramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Bromodiphenhydramine.
Brompheniramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Brompheniramine.
Buclizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Buclizine.
Budesonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Budesonide.
Bupivacaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Bupivacaine.
Butamben
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Butamben.
Butriptyline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Butriptyline.
Butyrate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Butyric Acid.
Butyric Acid
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Butyric Acid.
Capsaicin
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Capsaicin.
Carbinoxamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Carbinoxamine.
Cariprazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cariprazine.
Cetirizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cetirizine.
Chlophedianol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clofedanol.
Chlorcyclizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorcyclizine.
Chlordiazepoxide
The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Hyaluronidase.
Chloroprocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Chloroprocaine.
Chloropyramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chloropyramine.
Chlorotrianisene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorotrianisene.
Chlorpheniramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenamine.
Chlorphenoxamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorphenoxamine.
Chlorpromazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorpromazine.
Chlorprothixene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorprothixene.
Ciclesonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ciclesonide.
Cimetidine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cimetidine.
Cinnarizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cinnarizine.
Clemastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clemastine.
Clobazam
The therapeutic efficacy of Clobazam can be decreased when used in combination with Hyaluronidase.
Clobetasol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clobetasol.
Clobetasol Propionate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clobetasol propionate.
Clobetasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clobetasone.
Clocortolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clocortolone.
Clonazepam
The therapeutic efficacy of Clonazepam can be decreased when used in combination with Hyaluronidase.
Clonidine
Hyaluronidase may increase the vasoconstricting activities of Clonidine.
Clorazepate
The therapeutic efficacy of Clorazepate can be decreased when used in combination with Hyaluronidase.
CLORAZEPIC ACID
The therapeutic efficacy of Clorazepate can be decreased when used in combination with Hyaluronidase.
Clozapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Clozapine.
Cocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Cocaine.
Cortisone Acetate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cortisone acetate.
Cyclizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cyclizine.
Cyproheptadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Cyproheptadine.
Deflazacort
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Deflazacort.
Desipramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desipramine.
Desloratadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desloratadine.
Desonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desonide.
Desoximetasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desoximetasone.
Desoxycorticosterone acetate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desoxycorticosterone acetate.
Desoxycorticosterone Pivalate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Desoxycorticosterone Pivalate.
Dexamethasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexamethasone.
Dexbrompheniramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexbrompheniramine.
Dexchlorpheniramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexchlorpheniramine.
Dexchlorpheniramine maleate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dexchlorpheniramine maleate.
Dexmedetomidine
Hyaluronidase may increase the vasoconstricting activities of Dexmedetomidine.
Diazepam
The therapeutic efficacy of Diazepam can be decreased when used in combination with Hyaluronidase.
Dibucaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Cinchocaine.
Dienestrol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dienestrol.
Diethylstilbestrol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diethylstilbestrol.
Diflorasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diflorasone.
Diflucortolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Difluocortolone.
Diflunisal
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diflunisal.
Difluprednate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Difluprednate.
Dihydroergotamine
Hyaluronidase may increase the vasoconstricting activities of Dihydroergotamine.
Dimenhydrinate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimenhydrinate.
Dimethindene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimetindene.
Diphenhydramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diphenhydramine.
Diphenylpyraline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Diphenylpyraline.
Dipivefrin
Hyaluronidase may increase the vasoconstricting activities of Dipivefrin.
Dopamine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Dopamine.
Dothiepin
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dosulepin.
Doxepin
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Doxepin.
Doxylamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Doxylamine.
Droxidopa
Hyaluronidase may increase the vasoconstricting activities of Droxidopa.
Dyclonine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Dyclonine.
Ebastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ebastine.
Emedastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Emedastine.
Ephedrine
Hyaluronidase may increase the vasoconstricting activities of Ephedrine.
Epinastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Epinastine.
Epinephrine
Hyaluronidase may increase the vasoconstricting activities of Epinephrine.
Equol, (-)-
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Equol.
Ergonovine
Hyaluronidase may increase the vasoconstricting activities of Ergonovine.
Ergotamine
Hyaluronidase may increase the vasoconstricting activities of Ergotamine.
Escitalopram
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Escitalopram.
Estazolam
The therapeutic efficacy of Estazolam can be decreased when used in combination with Hyaluronidase.
Estradiol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estradiol.
Estradiol acetate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estradiol acetate.
Estradiol Cypionate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estradiol cypionate.
Estradiol Valerate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estradiol valerate.
Estriol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estriol.
Estrogens, Conjugated (USP)
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.
Estrogens, Esterified (USP)
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estrogens, esterified.
Estrone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estrone.
Ethinyl Estradiol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ethinyl Estradiol.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Ethyl chloride.
Etidocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Etidocaine.
Etilefrine
Hyaluronidase may increase the vasoconstricting activities of Etilefrine.
Etomidate
Hyaluronidase may increase the vasoconstricting activities of Etomidate.
Famotidine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Famotidine.
Fexofenadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fexofenadine.
Fludrocortisone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fludrocortisone.
Flumethasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flumethasone.
Flunarizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunarizine.
Flunisolide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunisolide.
Flunisolide Anhydrous (obsolete)
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flunisolide.
Flunitrazepam
The therapeutic efficacy of Flunitrazepam can be decreased when used in combination with Hyaluronidase.
Fluocinolone Acetonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluocinolone Acetonide.
Fluocinonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluocinonide.
Fluocortolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluocortolone.
Fluorometholone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluorometholone.
FLUPREDNIDENE
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluprednidene.
Fluprednisolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluprednisolone.
Flurandrenolide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Flurandrenolide.
Flurazepam
The therapeutic efficacy of Flurazepam can be decreased when used in combination with Hyaluronidase.
Fluticasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluticasone.
Fluticasone Furoate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluticasone furoate.
Fluticasone propionate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Fluticasone propionate.
Fonazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimetotiazine.
Formestane
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Formestane.
Furosemide
The therapeutic efficacy of Furosemide can be decreased when used in combination with Hyaluronidase.
Genistein
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Genistein.
Guanabenz
Hyaluronidase may increase the vasoconstricting activities of Guanabenz.
Guanfacine
Hyaluronidase may increase the vasoconstricting activities of Guanfacine.
Halcinonide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Halcinonide.
Halobetasol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ulobetasol.
Hydrocortisone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Hydrocortisone.
Hydroxyzine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Hydroxyzine.
Iloperidone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Iloperidone.
Imipramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Imipramine.
Isometheptene
Hyaluronidase may increase the vasoconstricting activities of Isometheptene.
Isothipendyl
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Isothipendyl.
Ketotifen
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ketotifen.
Levobupivacaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Levobupivacaine.
Levocabastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Levocabastine.
Levocetirizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Levocetirizine.
Lidocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Lidocaine.
Lodoxamide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Lodoxamide.
Lofexidine
Hyaluronidase may increase the vasoconstricting activities of Lofexidine.
Loratadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Loratadine.
Lorazepam
The therapeutic efficacy of Lorazepam can be decreased when used in combination with Hyaluronidase.
Lormetazepam
The therapeutic efficacy of Lormetazepam can be decreased when used in combination with Hyaluronidase.
Loteprednol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Loteprednol.
Maprotiline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Maprotiline.
Meclizine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Meclizine.
Medrysone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Medrysone.
Mephentermine
Hyaluronidase may increase the vasoconstricting activities of Mephentermine.
Mepivacaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Mepivacaine.
Mequitazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mequitazine.
Mesalamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mesalazine.
Mestranol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mestranol.
Metaraminol
Hyaluronidase may increase the vasoconstricting activities of Metaraminol.
Methamphetamine
Hyaluronidase may increase the vasoconstricting activities of Methamphetamine.
Methantheline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methantheline.
Methapyrilene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methapyrilene.
Methdilazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methdilazine.
Methotrimeprazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methotrimeprazine.
Methoxamine
Hyaluronidase may increase the vasoconstricting activities of Methoxamine.
Methyl Salicylate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methyl salicylate.
Methyldopa
Hyaluronidase may increase the vasoconstricting activities of Methyldopa.
METHYLDOPA ANHYDROUS
Hyaluronidase may increase the vasoconstricting activities of Methyldopa.
METHYLEPHEDRINE, DL-
Hyaluronidase may increase the vasoconstricting activities of DL-Methylephedrine.
Methylprednisolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Methylprednisolone.
Mianserin
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mianserin.
Midazolam
The therapeutic efficacy of Midazolam can be decreased when used in combination with Hyaluronidase.
Midodrine
Hyaluronidase may increase the vasoconstricting activities of Midodrine.
Mirtazapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mirtazapine.
Mizolastine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mizolastine.
Mometasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mometasone.
Moxonidine
Hyaluronidase may increase the vasoconstricting activities of Moxonidine.
N-methylephedrine
Hyaluronidase may increase the vasoconstricting activities of DL-Methylephedrine.
Naphazoline
Hyaluronidase may increase the vasoconstricting activities of Naphazoline.
Nitrazepam
The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Hyaluronidase.
Nizatidine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Nizatidine.
Nordazepam
The therapeutic efficacy of Nordazepam can be decreased when used in combination with Hyaluronidase.
Norepinephrine
Hyaluronidase may increase the vasoconstricting activities of Norepinephrine.
Nortriptyline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Nortriptyline.
Olanzapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Olanzapine.
Olopatadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Olopatadine.
Olsalazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Olsalazine.
Orphenadrine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Orphenadrine.
Oxatomide
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Oxatomide.
Oxazepam
The therapeutic efficacy of Oxazepam can be decreased when used in combination with Hyaluronidase.
Oxymetazoline
Hyaluronidase may increase the vasoconstricting activities of Oxymetazoline.
Paliperidone
Hyaluronidase may increase the vasoconstricting activities of Paliperidone.
Paramethasone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Paramethasone.
Pemirolast
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Pemirolast.
Pergolide
Hyaluronidase may increase the vasoconstricting activities of Pergolide.
Phendimetrazine
Hyaluronidase may increase the vasoconstricting activities of Phendimetrazine.
Phenindamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Phenindamine.
Pheniramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Pheniramine.
Phenol
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Phenol.
Phenylephrine
Hyaluronidase may increase the vasoconstricting activities of Phenylephrine.
Phenylpropanolamine
Hyaluronidase may increase the vasoconstricting activities of Phenylpropanolamine.
Phenytoin
The therapeutic efficacy of Phenytoin can be decreased when used in combination with Hyaluronidase.
Pizotyline
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Pizotifen.
Polyestradiol Phosphate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Polyestradiol phosphate.
Pramoxine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Pramocaine.
Prasterone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prasterone.
Prazepam
The therapeutic efficacy of Prazepam can be decreased when used in combination with Hyaluronidase.
Prednicarbate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednicarbate.
Prednisolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prednisone.
Pregnenolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Pregnenolone.
Prilocaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Prilocaine.
Procaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Procaine.
Prochlorperazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Prochlorperazine.
Profenamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ethopropazine.
Promazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Promazine.
Promestriene
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Promestriene.
Promethazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Proparacaine.
Propiomazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Propiomazine.
Pseudoephedrine
Hyaluronidase may increase the vasoconstricting activities of Pseudoephedrine.
Pyrilamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mepyramine.
Quazepam
The therapeutic efficacy of Quazepam can be decreased when used in combination with Hyaluronidase.
Quetiapine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Quetiapine.
Quinestrol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Quinestrol.
Racepinephrine
Hyaluronidase may increase the vasoconstricting activities of Racepinephrine.
Ranitidine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ranitidine.
Rilmenidine
Hyaluronidase may increase the vasoconstricting activities of Rilmenidine.
Rimexolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Rimexolone.
Risperidone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Risperidone.
Ropinirole
Hyaluronidase may increase the vasoconstricting activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Ropivacaine.
Roxatidine Acetate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Roxatidine acetate.
Salicylic Acid
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Salicylic acid.
Synephrine
Hyaluronidase may increase the vasoconstricting activities of Synephrine.
synthetic conjugated estrogens, A
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Synthetic Conjugated Estrogens, A.
synthetic conjugated estrogens, B
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Synthetic Conjugated Estrogens, B.
Temazepam
The therapeutic efficacy of Temazepam can be decreased when used in combination with Hyaluronidase.
Terfenadine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Terfenadine.
Tetracaine
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Tetracaine.
Tetrahydrozoline
Hyaluronidase may increase the vasoconstricting activities of Tetryzoline.
Thonzylamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Thonzylamine.
Tiapride
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tiapride.
Tibolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tibolone.
Tixocortol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tixocortol.
Tizanidine
Hyaluronidase may increase the vasoconstricting activities of Tizanidine.
Tranilast
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tranilast.
Trazodone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Trazodone.
Triamcinolone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triamcinolone.
Triazolam
The therapeutic efficacy of Triazolam can be decreased when used in combination with Hyaluronidase.
Trimeprazine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Alimemazine.
Trimipramine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Trimipramine.
Tripelennamine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tripelennamine.
Triprolidine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Triprolidine.
Tritoqualine
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Tritoqualine.
Trolamine Salicylate
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Trolamine salicylate.
Xylazine
Hyaluronidase may increase the vasoconstricting activities of Xylazine.
Xylometazoline
Hyaluronidase may increase the vasoconstricting activities of Xylometazoline.
Ziprasidone
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Ziprasidone.
Zuclopenthixol
The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Zuclopenthixol.
